Transport of amphipathic anions by human multidrug resistance protein 3
- PMID: 10987286
Transport of amphipathic anions by human multidrug resistance protein 3
Abstract
The multidrug resistance-associated protein 1 (MRP1) and the canalicular multispecific organic anion transporter (cMOAT or MRP2) are ATP-binding cassette transporters that confer resistance to some anticancer drugs and efflux glutathione and glucuronate conjugates from the cell. The MRP subfamily of ABC transporters, however, contains at least four other members of which MRP3 (MOAT-D) bears the closest structural resemblance to MRP1. Although transfection studies have established that human MRP3 confers increased resistance to several anticancer agents, neither the substrate selectivity nor physiological functions of this transporter have been determined. Here we report the results of investigations of the in vitro transport properties of cloned human MRP3 using membrane vesicles prepared from MRP3-transfected HEK293 cells. It is shown that the expression of MRP3 is specifically associated with enhancement of the MgATP-dependent transport into membrane vesicles of the glucuronide estradiol 17-beta-D-glucuronide (E(2)17betaG), the glutathione conjugates 2,4-dinitrophenyl S-glutathione (DNP-SG) and leukotriene C4 (LTC4), the antimetabolite methotrexate, and the bile acid glycocholate. DNP-SG, LTC4, and E(2)17betaG are transported at moderate affinity and low capacity with Km and Vmax values of 5.7 +/- 1.7 microM and 3.8 +/- 0.1 pmol/mg/min, 5.3 +/- 2.6 microM and 20.2 +/- 5.9 pmol/mg/min, and 25.6 +/- 5.4 microM and 75.6 +/- 5.9 pmol/mg/min, respectively. Methotrexate and glycocholate are transported at low affinity and high capacity with Km and Vmax values of 776 +/- 319 microM and 288 +/- 54 pmol/mg/min and 248 +/- 113 microM and 183 +/- 34 pmol/mg/min, respectively. On the basis of these findings, the osmotic dependence of the transport measured and its inability to transport taurocholate, MRP3, like MRP1 and cMOAT, is concluded to be competent in the transport of glutathione S-conjugates, glucuronides, and methotrexate, albeit at low to moderate affinity. In contrast to MRP1, cMOAT, and all other characterized mammalian ABC transporters, however, MRP3 is active in the transport of the monoanionic human bile constituent glycocholate.
Similar articles
-
ATP-dependent transport of bilirubin glucuronides by the multidrug resistance protein MRP1 and its hepatocyte canalicular isoform MRP2.Biochem J. 1997 Oct 1;327 ( Pt 1)(Pt 1):305-10. doi: 10.1042/bj3270305. Biochem J. 1997. PMID: 9355767 Free PMC article.
-
Function and expression of multidrug resistance-associated protein family in human colon adenocarcinoma cells (Caco-2).J Pharmacol Exp Ther. 2000 Jan;292(1):265-70. J Pharmacol Exp Ther. 2000. PMID: 10604957
-
ATP-dependent transport of bile salts by rat multidrug resistance-associated protein 3 (Mrp3).J Biol Chem. 2000 Jan 28;275(4):2905-10. doi: 10.1074/jbc.275.4.2905. J Biol Chem. 2000. PMID: 10644759
-
ATP-dependent transport of glutathione S-conjugates by the multidrug resistance protein MRP1 and its apical isoform MRP2.Chem Biol Interact. 1998 Apr 24;111-112:153-61. doi: 10.1016/s0009-2797(97)00158-0. Chem Biol Interact. 1998. PMID: 9679551 Review.
-
[Analysis of xenobiotic detoxification system mediated by efflux transporters].Yakugaku Zasshi. 1999 Nov;119(11):822-34. doi: 10.1248/yakushi1947.119.11_822. Yakugaku Zasshi. 1999. PMID: 10590710 Review. Japanese.
Cited by
-
Placing steroid hormones within the human ABCC3 transporter reveals a compatible amphiphilic substrate-binding pocket.EMBO J. 2023 Sep 4;42(17):e113415. doi: 10.15252/embj.2022113415. Epub 2023 Jul 24. EMBO J. 2023. PMID: 37485728
-
Clinical Significance of Lipid Transport Function of ABC Transporters in the Innate Immune System.Membranes (Basel). 2022 Oct 31;12(11):1083. doi: 10.3390/membranes12111083. Membranes (Basel). 2022. PMID: 36363640 Free PMC article. Review.
-
Role and Regulation of Hepatobiliary ATP-Binding Cassette Transporters during Chemical-Induced Liver Injury.Drug Metab Dispos. 2022 Oct;50(10):1376-1388. doi: 10.1124/dmd.121.000450. Epub 2022 Aug 1. Drug Metab Dispos. 2022. PMID: 35914951 Free PMC article. Review.
-
Overcome Drug Resistance in Cholangiocarcinoma: New Insight Into Mechanisms and Refining the Preclinical Experiment Models.Front Oncol. 2022 Mar 17;12:850732. doi: 10.3389/fonc.2022.850732. eCollection 2022. Front Oncol. 2022. PMID: 35372014 Free PMC article. Review.
-
Targeting Lymphangiogenesis and Lymph Node Metastasis in Liver Cancer.Am J Pathol. 2021 Dec;191(12):2052-2063. doi: 10.1016/j.ajpath.2021.08.011. Epub 2021 Sep 9. Am J Pathol. 2021. PMID: 34509441 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Research Materials
Miscellaneous